Ring Therapeutics, Inc
Ring Therapeutics, Inc., located in Cambridge, MA, is at the forefront of pioneering programmable genetic medicines through its innovative Anellogy platform, which capitalizes on the natural human commensal virome. By engineering viral-based therapies, the company aims to deliver targeted treatments safely and effectively to specific cells and tissues.
Leveraging the unique properties and capabilities of anelloviruses, Ring develops therapies that are versatile, potent, and capable of evading the immune system, thereby enhancing their therapeutic potential. With a commitment to pushing the boundaries of medical science, the company is assembling a team of leading experts dedicated to transforming these revolutionary approaches into life-saving therapies for patients in need.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Partial Data by Foursquare.